# Protillion Biosciences, lnc. — Form D

Protillion Biosciences, lnc. of BURLINGAME, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-21. The offering totals $20.7M, of which $19.0M was reported sold. Industry: Other.

## Offering

- Filed: 2022-12-21
- Form: D
- Accession: 0001959255-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $20.7M
- Amount sold: $19.0M
- Remaining: $1.7M
- Investors: 9
- Date of first sale: 2022-12-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-468247

## Issuer

- Name: Protillion Biosciences, lnc.
- CIK: 0001959255
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1400 MARSTEN RD. STE. M, BURLINGAME, CA, 94010
- Phone: 801-592-4108

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Malek Faham | Director | Goleta, CA |
| Sean Kendall | Director | Durham, NC |
| Curtis Layton | Director | Burlingame, CA |
| David Walt | Director | Cambridge, MA |
| Curtis Layton | Executive Officer | Burlingame, CA |

## More

- [CIK 1959255 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1959255&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001959255-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.